nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylnaltrexone—Naloxone—TLR4—IgA glomerulonephritis	0.0786	0.889	CrCbGaD
Methylnaltrexone—Naloxone—ALB—IgA glomerulonephritis	0.00982	0.111	CrCbGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—CCR2—IgA glomerulonephritis	0.00204	0.00223	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—ADORA3—IgA glomerulonephritis	0.00202	0.00222	CbGpPWpGaD
Methylnaltrexone—OPRM1—Peptide ligand-binding receptors—AGT—IgA glomerulonephritis	0.00201	0.00221	CbGpPWpGaD
Methylnaltrexone—OPRK1—G alpha (i) signalling events—AGT—IgA glomerulonephritis	0.00201	0.00221	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCRs, Class A Rhodopsin-like—CCR5—IgA glomerulonephritis	0.00201	0.00221	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—NMU—IgA glomerulonephritis	0.00199	0.00218	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—ECT2—IgA glomerulonephritis	0.00198	0.00217	CbGpPWpGaD
Methylnaltrexone—OPRK1—Peptide ligand-binding receptors—CCL2—IgA glomerulonephritis	0.00196	0.00215	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—METAP2—IgA glomerulonephritis	0.00196	0.00215	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—GPR65—IgA glomerulonephritis	0.00195	0.00214	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—PSAP—IgA glomerulonephritis	0.00191	0.0021	CbGpPWpGaD
Methylnaltrexone—OPRM1—Opioid Signalling—MAPK1—IgA glomerulonephritis	0.0019	0.00208	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—PTHLH—IgA glomerulonephritis	0.00188	0.00206	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—RGS4—IgA glomerulonephritis	0.00187	0.00205	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—NMU—IgA glomerulonephritis	0.00185	0.00203	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—ADORA3—IgA glomerulonephritis	0.00183	0.00201	CbGpPWpGaD
Methylnaltrexone—OPRM1—G alpha (i) signalling events—CCR5—IgA glomerulonephritis	0.00183	0.00201	CbGpPWpGaD
Methylnaltrexone—OPRM1—G alpha (i) signalling events—C3—IgA glomerulonephritis	0.00179	0.00196	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—CCR1—IgA glomerulonephritis	0.00178	0.00196	CbGpPWpGaD
Methylnaltrexone—OPRM1—TCR Signaling Pathway—TGFB1—IgA glomerulonephritis	0.00178	0.00195	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—GPR65—IgA glomerulonephritis	0.00177	0.00194	CbGpPWpGaD
Methylnaltrexone—OPRM1—TCR Signaling Pathway—MAPK1—IgA glomerulonephritis	0.00174	0.00191	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—RGS4—IgA glomerulonephritis	0.00174	0.00191	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—IgA glomerulonephritis	0.00172	0.00189	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—CCR2—IgA glomerulonephritis	0.00172	0.00189	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—ADORA3—IgA glomerulonephritis	0.00171	0.00187	CbGpPWpGaD
Methylnaltrexone—OPRM1—G alpha (i) signalling events—AGT—IgA glomerulonephritis	0.0017	0.00186	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—IgA glomerulonephritis	0.0017	0.00186	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—C3—IgA glomerulonephritis	0.00168	0.00185	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—NMU—IgA glomerulonephritis	0.00168	0.00184	CbGpPWpGaD
Methylnaltrexone—OPRM1—Peptide ligand-binding receptors—CCL2—IgA glomerulonephritis	0.00166	0.00182	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—C5AR1—IgA glomerulonephritis	0.00166	0.00182	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—METAP2—IgA glomerulonephritis	0.00166	0.00182	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—GPR65—IgA glomerulonephritis	0.00165	0.00181	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—ATP6V1B2—IgA glomerulonephritis	0.00162	0.00178	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—TMED2—IgA glomerulonephritis	0.00162	0.00178	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CCR1—IgA glomerulonephritis	0.00162	0.00178	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGT—IgA glomerulonephritis	0.0016	0.00175	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—RGS4—IgA glomerulonephritis	0.00158	0.00173	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—ADORA3—IgA glomerulonephritis	0.00155	0.0017	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—CCR1—IgA glomerulonephritis	0.00151	0.00165	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—C5AR1—IgA glomerulonephritis	0.00151	0.00165	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—GPR65—IgA glomerulonephritis	0.0015	0.00164	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—IgA glomerulonephritis	0.00146	0.0016	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—GNG12—IgA glomerulonephritis	0.00143	0.00157	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—FPR3—IgA glomerulonephritis	0.00143	0.00157	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—C3—IgA glomerulonephritis	0.00142	0.00156	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—C5AR1—IgA glomerulonephritis	0.0014	0.00154	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—ECT2—IgA glomerulonephritis	0.00138	0.00152	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—ATP6V1B2—IgA glomerulonephritis	0.00137	0.00151	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—TMED2—IgA glomerulonephritis	0.00137	0.00151	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CCR1—IgA glomerulonephritis	0.00137	0.0015	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGT—IgA glomerulonephritis	0.00135	0.00148	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PSAP—IgA glomerulonephritis	0.00134	0.00147	CbGpPWpGaD
Methylnaltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL2—IgA glomerulonephritis	0.00132	0.00144	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—CCR5—IgA glomerulonephritis	0.00131	0.00144	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—GNG12—IgA glomerulonephritis	0.0013	0.00143	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—ADAM12—IgA glomerulonephritis	0.0013	0.00142	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—C3—IgA glomerulonephritis	0.00128	0.00141	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—C5AR1—IgA glomerulonephritis	0.00127	0.0014	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—ABI1—IgA glomerulonephritis	0.00126	0.00139	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—PTHLH—IgA glomerulonephritis	0.00126	0.00138	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CAB39—IgA glomerulonephritis	0.00123	0.00135	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—AGT—IgA glomerulonephritis	0.00122	0.00134	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—GNG12—IgA glomerulonephritis	0.00121	0.00133	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—FPR3—IgA glomerulonephritis	0.00121	0.00133	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CCNC—IgA glomerulonephritis	0.00117	0.00129	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—NMU—IgA glomerulonephritis	0.00117	0.00129	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—ECT2—IgA glomerulonephritis	0.00117	0.00128	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—CCR2—IgA glomerulonephritis	0.00115	0.00126	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—PTHLH—IgA glomerulonephritis	0.00114	0.00125	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PSAP—IgA glomerulonephritis	0.00113	0.00124	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—IgA glomerulonephritis	0.00111	0.00122	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—CCR5—IgA glomerulonephritis	0.00111	0.00122	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—RGS4—IgA glomerulonephritis	0.0011	0.00121	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—GNG12—IgA glomerulonephritis	0.0011	0.00121	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—ADAM12—IgA glomerulonephritis	0.0011	0.0012	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—ADORA3—IgA glomerulonephritis	0.00108	0.00119	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—C3—IgA glomerulonephritis	0.00108	0.00119	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CMPK1—IgA glomerulonephritis	0.00107	0.00118	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—LYPLA1—IgA glomerulonephritis	0.00107	0.00118	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—ABI1—IgA glomerulonephritis	0.00107	0.00117	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—PTHLH—IgA glomerulonephritis	0.00106	0.00117	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—GPR65—IgA glomerulonephritis	0.00105	0.00115	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CCR2—IgA glomerulonephritis	0.00104	0.00115	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CAB39—IgA glomerulonephritis	0.00104	0.00114	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—AGT—IgA glomerulonephritis	0.00103	0.00113	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—CCL2—IgA glomerulonephritis	0.001	0.0011	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—UBE2D3—IgA glomerulonephritis	0.000999	0.0011	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CCNC—IgA glomerulonephritis	0.000993	0.00109	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—NMU—IgA glomerulonephritis	0.000993	0.00109	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—RACGAP1—IgA glomerulonephritis	0.000984	0.00108	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—CCR2—IgA glomerulonephritis	0.000972	0.00107	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—PTHLH—IgA glomerulonephritis	0.000965	0.00106	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—BCAT1—IgA glomerulonephritis	0.000958	0.00105	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—MINPP1—IgA glomerulonephritis	0.000958	0.00105	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—RPE—IgA glomerulonephritis	0.000958	0.00105	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—NNT—IgA glomerulonephritis	0.000958	0.00105	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—AZIN1—IgA glomerulonephritis	0.000958	0.00105	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CCR1—IgA glomerulonephritis	0.000957	0.00105	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—ITCH—IgA glomerulonephritis	0.000957	0.00105	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—TBL1XR1—IgA glomerulonephritis	0.000957	0.00105	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—RGS4—IgA glomerulonephritis	0.000933	0.00102	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—ADORA3—IgA glomerulonephritis	0.000916	0.001	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—VAV3—IgA glomerulonephritis	0.000905	0.000993	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—C5AR1—IgA glomerulonephritis	0.00089	0.000977	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—GPR65—IgA glomerulonephritis	0.000885	0.000971	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CCR2—IgA glomerulonephritis	0.000883	0.000968	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ADSS—IgA glomerulonephritis	0.000876	0.000961	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ETNK1—IgA glomerulonephritis	0.000876	0.000961	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—LPGAT1—IgA glomerulonephritis	0.000876	0.000961	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—SGPP1—IgA glomerulonephritis	0.000876	0.000961	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—CCL2—IgA glomerulonephritis	0.000848	0.00093	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—YES1—IgA glomerulonephritis	0.000845	0.000927	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—UBE2D3—IgA glomerulonephritis	0.000844	0.000926	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—RACGAP1—IgA glomerulonephritis	0.000832	0.000913	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—VAV3—IgA glomerulonephritis	0.000822	0.000901	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ATP5F1—IgA glomerulonephritis	0.000814	0.000893	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—AGL—IgA glomerulonephritis	0.000814	0.000893	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—KYNU—IgA glomerulonephritis	0.000814	0.000893	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—ITCH—IgA glomerulonephritis	0.000809	0.000888	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—TBL1XR1—IgA glomerulonephritis	0.000809	0.000888	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CCR1—IgA glomerulonephritis	0.000809	0.000888	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CHEK1—IgA glomerulonephritis	0.000807	0.000885	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CYBB—IgA glomerulonephritis	0.000793	0.00087	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—GNG12—IgA glomerulonephritis	0.000768	0.000843	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CHST2—IgA glomerulonephritis	0.000766	0.00084	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—MAT2A—IgA glomerulonephritis	0.000766	0.00084	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—VAV3—IgA glomerulonephritis	0.000765	0.000839	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—C5AR1—IgA glomerulonephritis	0.000752	0.000825	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—CCR5—IgA glomerulonephritis	0.000741	0.000813	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ELOVL6—IgA glomerulonephritis	0.000726	0.000796	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—IMPA1—IgA glomerulonephritis	0.000726	0.000796	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—DEGS1—IgA glomerulonephritis	0.000726	0.000796	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—NCF2—IgA glomerulonephritis	0.000726	0.000796	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—C3—IgA glomerulonephritis	0.000724	0.000795	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—YES1—IgA glomerulonephritis	0.000714	0.000783	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—RASA1—IgA glomerulonephritis	0.000707	0.000776	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—VAV3—IgA glomerulonephritis	0.000694	0.000762	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—EREG—IgA glomerulonephritis	0.00069	0.000757	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—AGT—IgA glomerulonephritis	0.000688	0.000755	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CHEK1—IgA glomerulonephritis	0.000682	0.000748	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PTHLH—IgA glomerulonephritis	0.000675	0.00074	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CCR5—IgA glomerulonephritis	0.000673	0.000738	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CYBB—IgA glomerulonephritis	0.000671	0.000736	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—UGCG—IgA glomerulonephritis	0.000664	0.000728	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—MARCKS—IgA glomerulonephritis	0.000664	0.000728	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—GLIPR1—IgA glomerulonephritis	0.000664	0.000728	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—GGCT—IgA glomerulonephritis	0.000664	0.000728	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—C3—IgA glomerulonephritis	0.000658	0.000722	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—GNG12—IgA glomerulonephritis	0.000649	0.000712	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PSME3—IgA glomerulonephritis	0.000637	0.000699	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—CCR5—IgA glomerulonephritis	0.000626	0.000687	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—AGT—IgA glomerulonephritis	0.000625	0.000686	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PDHX—IgA glomerulonephritis	0.000617	0.000677	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—GBE1—IgA glomerulonephritis	0.000617	0.000677	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—MTRR—IgA glomerulonephritis	0.000617	0.000677	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—AGPS—IgA glomerulonephritis	0.000617	0.000677	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CCR2—IgA glomerulonephritis	0.000617	0.000677	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—NCF2—IgA glomerulonephritis	0.000613	0.000673	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—C3—IgA glomerulonephritis	0.000612	0.000672	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PSAP—IgA glomerulonephritis	0.000598	0.000656	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—HEXB—IgA glomerulonephritis	0.000598	0.000656	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—RASA1—IgA glomerulonephritis	0.000598	0.000656	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CHUK—IgA glomerulonephritis	0.000589	0.000646	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—EREG—IgA glomerulonephritis	0.000583	0.00064	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—AGT—IgA glomerulonephritis	0.000582	0.000638	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—TNFRSF21—IgA glomerulonephritis	0.00058	0.000637	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—SAT1—IgA glomerulonephritis	0.00058	0.000637	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PTHLH—IgA glomerulonephritis	0.00057	0.000625	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CCR5—IgA glomerulonephritis	0.000569	0.000624	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—MTMR3—IgA glomerulonephritis	0.000564	0.000619	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—C3—IgA glomerulonephritis	0.000556	0.00061	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PSME3—IgA glomerulonephritis	0.000539	0.000591	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—AGT—IgA glomerulonephritis	0.000528	0.000579	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CCNC—IgA glomerulonephritis	0.000525	0.000576	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—GNS—IgA glomerulonephritis	0.000525	0.000576	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—MAP3K7—IgA glomerulonephritis	0.000523	0.000574	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CCR2—IgA glomerulonephritis	0.000521	0.000572	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—H2AFZ—IgA glomerulonephritis	0.00052	0.00057	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—ADAM10—IgA glomerulonephritis	0.000517	0.000567	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CCL2—IgA glomerulonephritis	0.000515	0.000565	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—RHOA—IgA glomerulonephritis	0.00051	0.00056	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—IQGAP1—IgA glomerulonephritis	0.000503	0.000552	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CHUK—IgA glomerulonephritis	0.000498	0.000546	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—HPSE—IgA glomerulonephritis	0.000493	0.000541	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—VAV3—IgA glomerulonephritis	0.000485	0.000532	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—HMMR—IgA glomerulonephritis	0.000468	0.000513	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—UCP2—IgA glomerulonephritis	0.000468	0.000513	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—RHOA—IgA glomerulonephritis	0.000463	0.000508	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ACSL1—IgA glomerulonephritis	0.000453	0.000497	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—MAP3K7—IgA glomerulonephritis	0.000442	0.000485	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—H2AFZ—IgA glomerulonephritis	0.000439	0.000482	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—ADAM10—IgA glomerulonephritis	0.000437	0.000479	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CCL2—IgA glomerulonephritis	0.000435	0.000477	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—RHOA—IgA glomerulonephritis	0.000431	0.000473	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—SEC23A—IgA glomerulonephritis	0.000428	0.000469	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—TBL1XR1—IgA glomerulonephritis	0.000428	0.000469	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ALOX5AP—IgA glomerulonephritis	0.000417	0.000457	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—YWHAZ—IgA glomerulonephritis	0.000413	0.000453	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—VAV3—IgA glomerulonephritis	0.00041	0.00045	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CCR5—IgA glomerulonephritis	0.000398	0.000436	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—RHOA—IgA glomerulonephritis	0.000392	0.00043	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—C3—IgA glomerulonephritis	0.000389	0.000426	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—AGT—IgA glomerulonephritis	0.000369	0.000405	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—YWHAZ—IgA glomerulonephritis	0.000349	0.000383	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—GNG12—IgA glomerulonephritis	0.000343	0.000377	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—RRM2—IgA glomerulonephritis	0.000343	0.000377	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CCR5—IgA glomerulonephritis	0.000336	0.000369	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—C3—IgA glomerulonephritis	0.000328	0.00036	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CD80—IgA glomerulonephritis	0.000327	0.000359	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—NRAS—IgA glomerulonephritis	0.000326	0.000358	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—NAMPT—IgA glomerulonephritis	0.000318	0.000349	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—AGT—IgA glomerulonephritis	0.000312	0.000342	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CCL2—IgA glomerulonephritis	0.000304	0.000334	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—MAPK1—IgA glomerulonephritis	0.000297	0.000326	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PSME3—IgA glomerulonephritis	0.000285	0.000312	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—PIK3CA—IgA glomerulonephritis	0.000284	0.000312	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—SERPINE1—IgA glomerulonephritis	0.000284	0.000311	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CD80—IgA glomerulonephritis	0.000276	0.000303	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—NRAS—IgA glomerulonephritis	0.000276	0.000303	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—RHOA—IgA glomerulonephritis	0.000274	0.0003	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—PIK3CA—IgA glomerulonephritis	0.000258	0.000283	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CCL2—IgA glomerulonephritis	0.000257	0.000282	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CD44—IgA glomerulonephritis	0.000256	0.000281	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—MAPK1—IgA glomerulonephritis	0.000251	0.000276	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ABCA1—IgA glomerulonephritis	0.000246	0.00027	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—PIK3CA—IgA glomerulonephritis	0.00024	0.000264	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—SERPINE1—IgA glomerulonephritis	0.00024	0.000263	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—RHOA—IgA glomerulonephritis	0.000231	0.000254	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—PIK3CA—IgA glomerulonephritis	0.000218	0.000239	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—MMP9—IgA glomerulonephritis	0.000217	0.000239	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PTEN—IgA glomerulonephritis	0.000216	0.000237	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—HMOX1—IgA glomerulonephritis	0.000211	0.000231	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—TYMS—IgA glomerulonephritis	0.000199	0.000218	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—NRAS—IgA glomerulonephritis	0.000193	0.000212	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—MMP9—IgA glomerulonephritis	0.000184	0.000202	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CD36—IgA glomerulonephritis	0.000183	0.000201	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PTEN—IgA glomerulonephritis	0.000183	0.0002	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—TGFB1—IgA glomerulonephritis	0.000179	0.000197	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—MAPK1—IgA glomerulonephritis	0.000176	0.000193	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—AGT—IgA glomerulonephritis	0.000165	0.000181	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—NRAS—IgA glomerulonephritis	0.000163	0.000179	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PIK3CA—IgA glomerulonephritis	0.000152	0.000167	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—TGFB1—IgA glomerulonephritis	0.000151	0.000166	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—MAPK1—IgA glomerulonephritis	0.000149	0.000163	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PIK3CA—IgA glomerulonephritis	0.000129	0.000141	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ALB—IgA glomerulonephritis	0.000127	0.000139	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PTEN—IgA glomerulonephritis	9.66e-05	0.000106	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PIK3CA—IgA glomerulonephritis	6.81e-05	7.47e-05	CbGpPWpGaD
